首页> 中国专利> 丹参酮ⅡA在制备治疗马拉色菌引起皮肤病的药物中的应用

丹参酮ⅡA在制备治疗马拉色菌引起皮肤病的药物中的应用

页面导航

摘要
著录项
法律信息
相似文献

摘要

本发明公开了丹参酮ⅡA在制备用于治疗马拉色菌引起的皮肤疾病中的药物中的应用，具体表现为在由马拉色菌繁殖而引起的头屑过多、特应性皮炎、脂溢性皮炎和银屑病中的应用。

著录项

公开/公告号CN103083333A

专利类型发明专利
公开/公告日2013-05-08

原文格式PDF
申请/专利权人上海莱博生物科技有限公司;
展开▼

申请/专利号CN201310023817.6
发明设计人孙常磊;朱丽平;李成亮;
展开▼

申请日2013-01-22
分类号A61K31/58;A61P31/04;A61P17/00;A61P17/08;A61P17/06;A61K8/63;A61Q5/12;A61Q5/02;A61Q19/10;A61Q19/00;
代理机构上海宏威知识产权代理有限公司;
代理人金利琴
地址 200233 上海市徐汇区桂平路333号1号楼8楼701室
入库时间 2024-02-19 17:28:06

法律信息

法律状态公告日

法律状态信息

法律状态
2015-03-25

发明专利申请公布后的视为撤回 IPC(主分类):A61K31/58 申请公布日:20130508 申请日:20130122

发明专利申请公布后的视为撤回
2013-06-12

实质审查的生效 IPC(主分类):A61K31/58 申请日:20130122

实质审查的生效
2013-05-08

公开

公开

相似文献

专利
中文文献
外文文献

1. 丹参酮ⅡA在制备治疗马拉色菌引起皮肤病的药物中的应用 [P] . 中国专利： CN103083333A . 2013-05-08
2. 厚朴酚在制备治疗马拉色菌引起皮肤病的外用制剂和日化品中应用 [P] . 中国专利： CN102218048A . 2011-10-19
3. composition, pharmaceutical composition, effervescent dosage form, multiple unit oral oral pharmaceutical composition, extended release pharmaceutical dosage form, enteric coated pharmaceutical dosage form, stable pharmaceutical dosage form for oral administration to mammalian subjects, method for treating diseases acid-related diseases by inhibiting gastric acid secretion, method for treating a bacterial infection caused or caused by helicobacter pylori, process for preparing a compound of formula 3, process for preparing a compound of formula 5, use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion, use of a compound of formula 1 for the preparation of a medicament for treating a bacterial infection caused or caused by helicobacter pyl or use of a compound of formula 1 for the preparation of a medicament for treating gastric acid-related diseases by inhibiting gastric acid secretion [P] . BRPI0617987A2 . 2011-08-16

机译：组合物，药物组合物，泡腾剂型，多单位口服口服药物组合物，缓释药物剂型，肠溶衣药物剂型，向哺乳动物受试者口服给药的稳定药物剂型，通过抑制胃酸治疗疾病的方法酸分泌，治疗由幽门螺杆菌引起或引起的细菌感染的方法，制备式3化合物的方法，制备式5化合物的方法，式1化合物在制备用于治疗胃的药物中的用途通过抑制胃酸分泌来治疗与酸有关的疾病，将式1的化合物用于制备用于治疗由幽门螺杆菌引起或引起的细菌感染的药物，或将式1的化合物用于制备用于治疗的药物通过抑制胃酸分泌来治疗胃酸相关疾病
4. DNA was isolated and purified, peptu00ecdeo, sequences of amino acids of human and murine sphk2, construction of recombinant DNA, host cell.Methods for producing a peptu00ecdeo of sphingosine kinase type 2 isoform of mouse and human.And to detect an agent or a drug that inhibits or promotes the activity of sphingosine kinase type 2, agent or product, methods for regulating a biological process in a mamu00ecfero,For the treatment or the improvement of a disease resulting from cell death increased or reduced cell proliferation.For the treatment or management of a disease resulting from reduced cell death or cell proliferation increased.And for the treatment or the improvement of a disease resulting from abnormal migration or motility of cells selected from the group consisted of cancer, restenose and diabetic neuropathy.Composition for the treatment or the improvement of UIMA disease resulting from cell death increased or reduced cell proliferation.Methods for screening for agents or [P] . BR0109827A . 2004-07-06

机译：分离纯化DNA，肽，人和鼠sphk2的氨基酸序列，重组DNA的构建，宿主细胞。小鼠和人2型鞘氨醇激酶2型亚型的肽的制备方法，并检测抑制或促进2型鞘氨醇激酶活性的药物或药物，药物或产物的调节方法，用于治疗哺乳动物的生物学过程的方法，用于治疗或改善由细胞死亡引起的疾病的方法，增加或减少的细胞增殖用于治疗或管理由减少的细胞死亡或细胞增殖引起的疾病，以及用于治疗或改善由癌症，再狭窄和糖尿病性神经病变组成的组中的细胞异常迁移或运动导致的疾病。用于治疗或改善由细胞死亡引起的UIMA疾病的组合物可增加或减少细胞增殖。
5. Application of a prolactin inhibitor compound to prepare a medicine for the treatment of an immune system dysfunction application of a prolactin stimulating compound to prepare a medicine for the treatment of an immune system dysfunction application of a prolactin stimulating compound to prepare a medicine for the treatment of an autoimmune disease and therapeutic package [P] . BR9507858A . 1997-11-04

机译：催乳激素抑制剂化合物在制备用于治疗免疫系统功能障碍的药物中的应用催乳激素刺激化合物在制备用于治疗免疫系统功能障碍的药物中的应用催乳激素刺激化合物在制备用于治疗免疫系统功能障碍的药物中的应用自身免疫性疾病和治疗方案